Abstract
A case of stage IB2 cervical cancer at 27 weeks of pregnancy, treated with neoadjuvant chemotherapy followed by radical Cesarean hysterectomy with full pelvic and infra-mesenteric lymphadenectomy, and adjuvant chemo-radiation is described. While she remains without disease, her baby was diagnosed with acute myelogenous leukemia. We highlight the pre-operative work-up, treatment options, safety, feasibility, and outcomes for the mother and her fetus.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 398-405 |
| Numero di pagine | 8 |
| Rivista | Gynecologic Oncology |
| Volume | 150 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2018 |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
-
SDG 3 Salute e benessere
Keywords
- Adult
- Antineoplastic Combined Chemotherapy Protocols
- Carcinoma, Squamous Cell
- Cervical cancer
- Cesarean Section
- Chemotherapy, Adjuvant
- Cisplatin
- Female
- Humans
- Hysterectomy
- Infant, Newborn
- Male
- Neoadjuvant Therapy
- Neoadjuvant chemotherapy
- Neoplasm Staging
- Obstetric outcome
- Obstetrics and Gynecology
- Oncology
- Paclitaxel
- Pregnancy
- Pregnancy Complications, Neoplastic
- Radical hysterectomy
- Salpingectomy
- Uterine Cervical Neoplasms
Fingerprint
Entra nei temi di ricerca di 'Locally advanced cervical cancer complicating pregnancy: A case of competing risks from the Catholic University of the Sacred Heart in Rome'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver